Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

MoonLake Immunotherapeutics

NASDAQ: MLTX · Life Sciences · 2 alerts · CIK 1821586

Share price
$11.73Close, Nov 16
Market cap
$998M
Shares outstanding
85.11MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All MoonLake Immunotherapeutics filings on SEC EDGAR ↗

7:07 AM ET 8-K
Financial Results

MoonLake Immunotherapeutics Financial Results

MoonLake Immunotherapeutics reported Q3 2026 financial results and announced the submission of a Biologics License Application (BLA) to the FDA for sonelokimab in hidradenitis suppurativa. The company ended the quarter with $498.5 million in cash and equivalents, providing a projected cash runway into mid-2028.

Term
Q3 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.